| Net Cash Provided by (Used in) Financing Activities |
-22M |
USD |
+84.2% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-18M |
USD |
+30.8% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
200M |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
46M |
shares |
-2.13% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-81M |
USD |
-452% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
76M |
USD |
+18.8% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability |
106M |
USD |
-10.9% |
Q3 2025 |
FY 2025 |
| Depreciation |
174M |
USD |
-12.1% |
Q3 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
23M |
USD |
-36.1% |
Q4 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
118M |
USD |
-25.8% |
Q3 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
3.36B |
USD |
+1.18% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
21M |
USD |
+5% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
18M |
USD |
0% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
23M |
USD |
0% |
Q3 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.04 |
pure |
0% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
12M |
USD |
-70% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
13M |
USD |
-7.14% |
Q3 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
65M |
USD |
0% |
Q3 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
9M |
USD |
-10% |
Q3 2025 |
FY 2025 |
| Operating Lease, Payments |
26M |
USD |
-3.7% |
Q3 2025 |
FY 2025 |
| Amortization of Intangible Assets |
63M |
USD |
-17.1% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
51M |
USD |
-33.8% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
236M |
USD |
-25.3% |
Q3 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
14M |
USD |
-17.6% |
Q3 2025 |
FY 2025 |